Danya Institute Inc.

News

Health Advocates Say Schizophrenia Should Be Reclassified as a Brain Disease

From Politico. by Brianna Ehley Changing the definition could unlock more money for cures. Mental health advocates are lobbying Congress to help them get schizophrenia classified as a brain disease like Parkinson’s or Alzheimer’s, instead of as a mental illness, a move that could reduce stigma and lead to more dollars for a cure. Federal […]


D.C. announces plan to cut opioid-related deaths by half

From the Washington Post. In long-awaited plan, D.C. aims to reduce opioid deaths by half by late 2020 by Jenna Portnoy The District on Monday announced a plan aimed at cutting opioid-related deaths by half over the next 21 months, using a long list of treatment, tracking and education initiatives. Start-up costs of $24 million will […]


Delaware overdose deaths could top 400 in 2018

From WHYY. By Eric Eichmann Through Christmas Day, 286 deaths from suspected overdoses have been reported in Delaware. When the final toxicology reports are completed in a few months, however, that number could soar to more than 400. “Regrettably, we’re trending above where we were last year,” said Kara Odom Walker, secretary of the state […]


Opioid Crisis Linked to Spike in Infective Endocarditis

From MedPageToday. by Nicole Lou — Ten-fold rise in one state prompts urgent call for action Drug-associated infective endocarditis increased more than 10-fold from 2007 to 2017 in step with the opioid crisis in one state, researchers reported. Annual hospitalizations related to the infection went from 0.92 to 10.95 per 100,000 persons during this time […]


Fantanyl Leads in Overdose Deaths

From CNN. Fentanyl is the Deadliest Drug in America, CDC Confirms by Nadia Kounang Fentanyl is now the most commonly used drug involved in drug overdoses, according to a new government report. The latest numbers from the US Centers for Disease Control and Prevention’s National Center for Health Statistics say that the rate of drug […]


Alert! Life-threatening outbreak associated with synthetic cannabinoids

From CDC Update—Outbreak of Life-threatening Coagulopathy Associated with Synthetic Cannabinoids Use Distributed via the CDC Health Alert Network December 10, 2018 1300 ET (1:00 PM ET) CDCHAN-00416   Summary The Centers for Disease Control and Prevention (CDC) is providing information on: 1) the current status of a multistate outbreak of coagulopathy from exposure to synthetic […]


Jail Ordered to Give Inmate Methadone for Opioid Addiction in Far-Reaching Ruling

From the NY Times by Kate Taylor BOSTON — In a ruling that could have tremendous consequences for the country’s correctional system, a federal judge said this week that a Massachusetts man facing a jail sentence could not be denied access to treatment for his opioid addiction. Judge Denise J. Casper of the United States […]


FDA Approves New Potent Opioid

From NPR. Despite Warnings, FDA Approves Potent New Opioid Painkiller by Jake Harper The Food and Drug Administration has approved a potent new opioid painkiller, despite warnings from physician critics who say the drug will contribute to the addiction epidemic. Dsuvia, a 3-millimeter-wide tablet of sufentanil made by AcelRx, came before an FDA advisory committee […]


Every U.S. Public Library and YMCA Will Soon Get Narcan for Free

From Time. by Jamie Ducharme Every public library and YMCA in the U.S. may soon be equipped with Narcan, in an effort to combat drug-related deaths by expanding access to the opioid-overdose-reversing naloxone nasal spray. Emergent BioSolutions, which this month completed its acquisition of Narcan maker Adapt Pharma, will provide a free kit including two doses of […]


HIV Preexposure Prophylaxis, by Race and Ethnicity — United States, 2014–2016

From the CDC. Huang YA, Zhu W, Smith DK, Harris N, Hoover KW. HIV Preexposure Prophylaxis, by Race and Ethnicity — United States, 2014–2016. MMWR Morb Mortal Wkly Rep 2018;67:1147–1150. DOI: http://dx.doi.org/10.15585/mmwr.mm6741a3 Preexposure prophylaxis (PrEP) with a daily, oral pill containing antiretroviral drugs is highly effective in preventing acquisition of human immunodeficiency virus (HIV) infection (1–4). […]